Bioo, Jungwoo Partner on Cancer MDx Technologies | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bioo Scientific and Jungwoo F&B are partnering in an effort to improve methods of cancer diagnosis and treatment, the Austin, Texas-based company said on Monday.

As part of the collaboration Bioo will develop kits for use on Jungwoo's Image Oriented Navigation Laser Microdissection Device imaging platform. Bioo will also develop kits for global microRNA profiling and for protein extraction for peptide analysis of tumor samples using mass spectrometry.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.